Détail de l'auteur
Auteur M. HICKMAN |
Documents disponibles écrits par cet auteur (108)
Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; C. BUCELLO ; J. LEMON ; L. WIESSING ; M. HICKMAN |FRANÇAIS : Objectif : Examiner systématiquement les études de cohortes de la mortalité chez les toxicomanes par injection, étudier les taux de mortalité et les causes de décès dans ce groupe, et identifier les variables, au niveau des participa[...]Article : Périodique
L. DEGENHARDT ; C. BUCELLO ; B. MATHERS ; C. BRIEGLEB ; H. ALI ; M. HICKMAN ; J. MCLAREN |AIMS: To review the literature on mortality among dependent or regular users of opioids across regions, according to specific causes, and related to a number of demographic and clinical variables. METHODS: Multiple search strategies included sea[...]Article : Périodique
M. HICKMAN ; D. DE ANGELIS ; H. JONES ; R. J. HARRIS ; N. WELTON ; A. E. ADES |The quality of the evidence on estimating drug-related harm is not yet as advanced as that for intervention effectiveness. Multiple parameter evidence synthesis offers a potential solution, in which 'all available evidence' is combined into a si[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]Article : Périodique
L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN |Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]Article : Périodique
V. D. HOPE ; J. V. PARRY ; F. NCUBE ; M. HICKMAN |Background: The extent of intentional or accidental subcutaneous and intramuscular injections and the factors associated with these have rarely been studied among people who inject drugs, yet these may play an important role in the acquisition b[...]Article : Périodique
G. J. MACARTHUR ; S. MINOZZI ; N. MARTIN ; P. VICKERMAN ; S. DEREN ; J. BRUNEAU ; L. DEGENHARDT ; M. HICKMAN |Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs. Design: Systematic review and meta-analysis of prospective published and unpublished observational studies. Data [...]Périodique
J. PARSONS ; M. HICKMAN ; P. J. TURNBULL ; T. McSWEENEY ; G. V. STIMSON ; A. JUDD ; K. ROBERTS | 2002FRANÇAIS : Le nombre de seringues distribuées en avril 1997 est estimé à 1 707 000 et celui de l'année à 27 millions, à partir de 2000 lieux d'échange dans le Royaume-Uni. Le nombre de seringues distribuées en Ecosse est 3 à 4 fois plus bas que[...]Article : Périodique
K. P. HAYHURST ; M. PIERCE ; M. HICKMAN ; T. SEDDON ; G. DUNN ; J. KEANE ; T. MILLAR |Background: Although evidence points to a strong link between illicit drug use and crime, robust evidence for temporal order in the relationship is scant. We carried out a systematic review to assess the evidence for pathways through opiate/crac[...]NouveautéArticle : Périodique
J. HERON ; J. MACLEOD ; M. R. MUNAFO ; R. MELOTTI ; G. LEWIS ; K. TILLING ; M. HICKMAN |AIMS: Teenagers in the UK report some of the highest rates of alcohol use in Europe. We identify patterns of alcohol use in early adolescence and relate these to hazardous and harmful alcohol use at age 16. METHODS: In a UK birth cohort, we an[...]Article : Périodique
M. TAYLOR ; S. M. COLLIN ; M. R. MUNAFO ; J. MACLEOD ; M. HICKMAN ; J. HERON |Background: Evidence on the role of cannabis as a gateway drug is inconsistent. We characterise patterns of cannabis use among UK teenagers aged 13-18 years, and assess their influence on problematic substance use at age 21 years. Methods: We u[...]Article : Périodique
Background and Aims: Peer-led interventions may offer a beneficial approach in preventing substance use, but their impact has not yet been quantified. We conducted a systematic review to investigate and quantify the effect of peer-led interventi[...]Article : Périodique
E. F. KANER ; F. R. BEYER ; C. GARNETT ; D. CRANE ; J. BROWN ; C. MUIRHEAD ; J. REDMORE ; A. O'DONNELL ; J. J. NEWHAM ; F. DE VOCHT ; M. HICKMAN ; H. BROWN ; G. MANIATOPOULOS ; S. MICHIE |Review question: We aimed to find out if personalised advice to reduce heavy drinking provided using a computer or mobile device is better than nothing or printed information. We also compared advice provided using a computer or mobile device to[...]Article : Périodique
F. R. BEYER ; R. P. W. KENNY ; E. JOHNSON ; D. M. CALDWELL ; C. GARNETT ; S. RICE ; J. SIMPSON ; C. ANGUS ; D. CRAIG ; M. HICKMAN ; S. MICHIE ; E. F. S. KANER |AIM: To compare the effectiveness of practitioner versus digitally delivered interventions for reducing hazardous and harmful alcohol consumption. DESIGN: Systematic review and network meta-analysis comprising comprehensive search for randomise[...]Article : Périodique
V. D. HOPE ; A. JUDD ; M. HICKMAN |OBJECTIVES: This study sought to establish the prevalence of hepatitis C antibodies (anti-HCV) and hepatitis B antibodies (anti-HBc) among injection drug users in England and Wales. METHODS: A voluntary cross-sectional survey collected oral flu[...]Périodique
Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study
T. RHODES ; L. PLATT ; S. MAXIMOVA ; E. KOSHKINA ; N. LATISHEVSKAYA ; M. HICKMAN ; A. RENTON ; N. BOBROVA ; T. McDONALD ; J. V. PARRY | 2006Objectives: To estimate the prevalence of HIV, hepatitis C virus (HCV) and syphilis in injecting drug users (IDUs) in Russia. Methods: Unlinked anonymous cross-sectional survey of 1473 IDUs recruited from non-treatment settings in Moscow, Volgog[...]Périodique
A. JUDD ; G. V. STIMSON ; M. HICKMAN ; G. M. HUNTER ; S. JONES ; J. V. PARRY ; P. MADDEN | 2000FRANÇAIS : 753 usagers de drogues injectables (UDVIs), recrutés dans 7 centres d'accueil anglais en 1997 et 1998, ont répondu à un questionnaire et ont fait l'objet d'un dépistage anonyme du VIH. La majorité était des hommes (71,1%) et près d'u[...]Article : Périodique
L. DEGENHARDT ; B. MATHERS ; P. VICKERMAN ; T. RHODES ; C. LATKIN ; M. HICKMAN |HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider community (by sexual transmission). Here, we summarise evidence on the effectiveness of individu[...]Article : Périodique
H. E. JONES ; N. J. WELTON ; A. E. ADES ; M. PIERCE ; W. DAVIES ; B. COLEMAN ; T. MILLAR ; M. HICKMAN |Background and Aims: Capture-recapture (CRC) analysis is recommended for estimating the prevalence of problem drug use or people who inject drugs (PWID). We aim to demonstrate how naive application of CRC can lead to highly misleading results, a[...]Article : Périodique
J. MACLEOD ; R. OAKES ; A. COPELLO ; I. CROME ; M. EGGER ; M. HICKMAN ; OPPENKOWSKI T. ; H. STOKES-LAMPARD ; G. DAVEY SMITH |BACKGROUND: Use of illicit drugs, particularly cannabis, by young people is widespread and is associated with several types of psychological and social harm. These relations might not be causal. Causal relations would suggest that recreational d[...]Périodique
T. RHODES ; J. KIMBER ; W. SMALL ; J. FITZGERALD ; T. KERR ; M. HICKMAN ; G. HOLLOWAY | 2006Background: One key structural dimension in the distribution of drug-related harm associated with injecting drug use is the injecting environment. Epidemiological evidence associates elevated blood-borne viral risk with injecting in 'public' and[...]Article : Périodique
J. GREBELY ; G. ROBAEYS ; P. BRUGGMANN ; A. AGHEMO ; M. BACKMUND ; J. BRUNEAU ; J. BYRNE ; O. DALGARD ; J. J. FELD ; M. HELLARD ; M. HICKMAN ; A. KAUTZ ; A. LITWIN ; A. R. LLOYD ; S. MAUSS ; M. PRINS ; T. SWAN ; M. SCHAEFER ; L. E. TAYLOR ; G. J. DORE |Dans les pays à revenus élevés, la majorité des infections par le virus de l'hépatite C (VHC) nouvelles et existantes se produisent chez usagers de drogues par injection (UDI). Dans de nombreux pays à revenus faibles et moyens, de vastes épidémi[...]Article : Périodique
This article discusses approaches to assessing the size of the illicit market for powder cocaine, and the inherent difficulties of this issue. It describes recent attempts to investigate more accurate measures of the prevalence and extent of use[...]Article : Périodique
J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users |Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]NouveautéArticle : Périodique
H. L. MILLS ; C. COLIJN ; P. VICKERMAN ; D. LESLIE ; V. HOPE ; M. HICKMAN |Background: A 2006 respondent driven sampling (RDS) survey of injecting drug users (IDUs) in Bristol, UK, estimated 40 per 100 person years HCV incidence but in 2009 another RDS survey estimated only 10 per 100 person years incidence amongst the[...]